Cite
HARVARD Citation
Haczeyni, F. et al. (2017). The selective peroxisome proliferator–activated receptor‐delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. Hepatology communications. 1 (7), pp. 663-674. [Online].